Lax-Tab

Bisacodyl, the active ingredient in Lax-Tab, is a stimulant laxative presented as an unknown/unknown for oral use. It treats occasional constipation and related bowel‑cleansing needs in adults.

GNH USA supplies Lax-Tab as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lax-Tab (bisacodyl) is indicated for conditions affecting colonic motility and stool passage.

- Occasional constipation: provides relief by stimulating bowel movements in otherwise healthy adults. - Travel‑related constipation: helps normalize transit when diet or routine changes disrupt normal bowel function. - Bowel cleansing before diagnostic procedures: prepares the colon for colonoscopy or radiologic examinations by promoting evacuation.

Bisacodyl may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps or discomfort - Diarrhea or loose stools - Nausea or mild stomach upset - Rectal irritation or burning sensation - Urgency to defecate - Increased flatulence

Serious or Rare Side Effects: - Severe electrolyte imbalance leading to dehydration - Allergic reactions such as rash, itching, or swelling - Acute colitis or inflammation of the colon - Rectal bleeding or severe abdominal pain - Persistent diarrhea requiring medical attention

When using Lax-Tab, consider the following safety measures.

- Do not exceed the recommended dose: follow the prescriber's instructions. - Ensure adequate fluid intake: drink sufficient water to reduce dehydration risk. - Avoid use in patients with known intestinal obstruction or acute abdominal pain. - Use caution in elderly patients: monitor for excessive fluid loss. - Limit duration of regular use: prolonged therapy may cause dependence. - Store at below 25°C: keep in the original pack, protect from moisture.

Bisacodyl can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Anticholinergic agents: may reduce the laxative effect. - Loop diuretics: increase risk of electrolyte disturbances. - Cardiac glycosides: heightened risk of arrhythmias due to electrolyte shifts.

Moderate Interactions (Monitor Closely): - Antidepressants (especially SSRIs): potential for serotonin syndrome when combined with other serotonergic agents. - NSAIDs: additive gastrointestinal irritation. - Mineral supplements (e.g., calcium, iron): may diminish bisacodyl absorption.